Last reviewed · How we verify

NCT01061268

A Randomized Clinical Evaluation Pilot Study of the Efficacy of Blink® Tears Lubricant Eye Drops for the Relief of Dry Eye Symptoms Following Implantation of Tecnis® Multifocal Introcular Lens

Completed Phase 4 Last updated 15 February 2012
What this trial tests

Phase 4 trial testing No topical artificial tear in Dry Eye in 25 participants. Completed in 1 February 2012.

Timeline
1 January 2010
Primary endpoint
1 February 2012
1 February 2012

Quick facts

Lead sponsorInnovative Medical
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment25
Start date1 January 2010
Primary completion1 February 2012
Estimated completion1 February 2012
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Innovative Medical — full company profile →

Who can join

21 and older, any sex, with Dry Eye. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Sponsor's own description

To evaluate the safety and efficacy of BLINK™ tears compared with NO topical artificial tear use in improving subject's visual performance and reduce ocular symptoms of discomfort in subjects who have undergone cataract surgery implanted with a Tecnis™ diffractive multifocal intraocular lens (IOL).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Over the counter (OTC) artificial tear drops for dry eye syndrome.
    Pucker AD, Ng SM, Nichols JJ, Nichols JJ. · · 2016 · cited 108× · PMID 26905373 · DOI 10.1002/14651858.cd009729.pub2

Verify or expand the search:

Other recruiting trials for Dry Eye

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01061268.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing